Aeterna Zentaris Inc (NASDAQ:AEZS)

3.79
Delayed Data
As of Nov 25
 +0.01 / +0.26%
Today’s Change
3.51
Today|||52-Week Range
12.75
-57.33%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$17.8M

Company Description

Æterna Zentaris, Inc. operates as a specialty biopharmaceutical company, which engages in the development of therapeutics and diagnostic tests. Its product Macimorelin, is an oral growth hormone secretagogue receptor agonist indicated for the diagnosis of Adult Growth Hormone Deficiency. The company was founded on September 12, 1990 and is headquartered in Charleston, SC.

Contact Information

Æterna Zentaris, Inc.
222 Bay Street
Toronto Ontario M5K 1E7
P:(418) 652-8525
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Klaus Wolfgang PauliniPresident, Chief Executive Officer & Director
Giuliano La FrattaChief Financial Officer & Senior Vice President
Michael TeifelChief Scientific Officer & Senior Vice President
Nicola AmmerChief Medical Officer & Senior Vice President
Matthias GerlachVice President-Manufacturing & Supply Chain